Cable Hill Partners, LLC Cytosorbents Corp Transaction History

Cable Hill Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$5.92 - $7.78 $20,720 - $27,230	-3,500 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$7.05 - $12.64 $10,575 - $18,960	1,500 Added 75.0%	3,500 $28,000
Q3 2018 Nov 14, 2018	BUY	$10.95 - $14.8 $10,950 - $14,800	1,000 Added 100.0%	2,000 $24,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,000	1,000 $4,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.